79
Participants
Start Date
October 31, 2007
Primary Completion Date
February 28, 2010
Study Completion Date
May 31, 2010
Ramelteon
Subjects demonstrating low sleep efficiencies and prolonged sleep latencies, will be randomly assigned to continue to receive SHI accompanied by either placebo or Ramelteon (8 mg). Matching placebo will be obtained and the medication pre-packaged and ordered based on the randomization results.
Placebo
National Institutes of Health (NIH)
NIH
Emory University
OTHER